These data indicate that Nat10 also causes an enhanced proliferative impact on human cardiomyocytes by inhibiting Uqcr11 and Uqcrb expression, highlighting the translational regulation potential of Nat10 in the treatment of heart diseases. The gene discussed is NAT10; the disease is heart disorder.